Cargando…

In reply—COVID-19: Precision Medicine and Vascular Endothelium

Detalles Bibliográficos
Autores principales:	Cresci, Sharon, Ahmad, Ferhaan, Pereira, Naveen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055184/ https://www.ncbi.nlm.nih.gov/pubmed/34088425 http://dx.doi.org/10.1016/j.mayocp.2021.04.006

Ejemplares similares

COVID-19: Precision Medicine and Vascular Endothelium
por: Tricarico, Gerardo, et al.
Publicado: (2021)

COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
por: Pereira, Naveen L., et al.
Publicado: (2021)

Reply to: Endothelium-dependent and -independent functions in migraineurs
por: Fujioka, Kazumi
Publicado: (2018)

Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling
por: Kang, Sujin, et al.
Publicado: (2021)

Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
por: Ballow, Mark, et al.
Publicado: (2021)

Author's Reply
por: Mani, Raj Kumar, et al.
Publicado: (2015)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

Authors’ reply
por: Mohapatra, Prasanta R., et al.
Publicado: (2011)

Reply to “The outbreak of COVID-19: An overview”
por: Wu, Yi-Chi, et al.
Publicado: (2020)

Reply: CPET for Long COVID-19
por: Mancini, Donna M., et al.
Publicado: (2022)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

Authors Reply
por: Farrell, Rosie, et al.
Publicado: (2007)

Reply to Consensus document on tracheotomy in patients with COVID 19()
por: Pérez Acosta, G., et al.
Publicado: (2021)

Reply to “Impact of COVID-19 on the mental health of radiologists”
por: Demirjian, Natalie L., et al.
Publicado: (2021)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Reply to “Pulmonary toxicity by oxygen and COVID-19”()
por: Belenguer-Muncharaz, A., et al.
Publicado: (2022)

Reply To: Response to COVID-19 by the surgical community
por: Chapman, Robert
Publicado: (2020)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Reply to professionally responsible COVID-19 vaccination counseling
por: Chervenak, Frank A., et al.
Publicado: (2021)

Reply - Management of vascular anomalies: Review of institutional management algorithm
por: Sahu, Shamendra Anand, et al.
Publicado: (2018)

Reply to: Cadaverless anatomy: Darkness in the times of pandemic Covid-19
por: Murlimanju, B.V., et al.
Publicado: (2020)

Precision medicine in colorectal cancer
por: Aziz, Mohammad Azhar
Publicado: (2019)

Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium?
por: Guler, Nil, et al.
Publicado: (2020)

'Post-COVID-19 chronic symptoms' – Author's reply
por: Davido, Benjamin, et al.
Publicado: (2021)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Reply to “Consensus document on tracheotomy in patients with COVID-19”()
por: Martín Delgado, M.C., et al.
Publicado: (2021)

Reply to: Trajectories of vital signs in patients with Covid-19
por: Redfern, Oliver C., et al.
Publicado: (2021)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

Reply to the letter concerning Kawasaki disease and Covid-19
por: Loomba, Rohit S., et al.
Publicado: (2020)

“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022)

Reply to “Tachycardia, adverse effect, COVID-19 vaccine”
por: Teresa Marco García, M., et al.
Publicado: (2023)

DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Author’s Reply
por: Nejad, Zahra Javady, et al.
Publicado: (2015)

In Reply to the Letter to the Editor Regarding “Impact of COVID-19 on Neurosurgical Training in Southeast Asia”
por: Baticulon, Ronnie E., et al.
Publicado: (2021)

Authors′ reply
por: Khalid, Mohd, et al.
Publicado: (2013)

Authors’ reply
por: Qureshi, Umar Amin, et al.
Publicado: (2010)

In Reply
por: Coomes, Eric A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5bp5neql78peu7ln2k153v9et9